BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 26675257)

  • 1. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
    Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
    Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
    Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
    Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
    Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
    J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
    Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
    PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.
    Zheng C; Guo K; Chen B; Wen Y; Xu Y
    Cancer Biomark; 2019; 26(2):193-202. PubMed ID: 31403941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
    Xu B; Tao T; Wang Y; Fang F; Huang Y; Chen S; Zhu W; Chen M
    Tumour Biol; 2016 Oct; 37(10):14141-14151. PubMed ID: 27524492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
    Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
    Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.
    Rodríguez M; Bajo-Santos C; Hessvik NP; Lorenz S; Fromm B; Berge V; Sandvig K; Linē A; Llorente A
    Mol Cancer; 2017 Oct; 16(1):156. PubMed ID: 28982366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-425-5p as an exosomal biomarker for metastatic prostate cancer.
    Rode MP; Silva AH; Cisilotto J; Rosolen D; Creczynski-Pasa TB
    Cell Signal; 2021 Nov; 87():110113. PubMed ID: 34371055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
    Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
    Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
    Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of dicer and its related miRNAs in the progression of prostate cancer.
    Bian X; Shen Y; Zhang G; Gu C; Cai Y; Wang C; Zhu Y; Zhu Y; Zhang H; Dai B; Ye D
    PLoS One; 2015; 10(3):e0120159. PubMed ID: 25768283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression.
    Ozen M; Karatas OF; Gulluoglu S; Bayrak OF; Sevli S; Guzel E; Ekici ID; Caskurlu T; Solak M; Creighton CJ; Ittmann M
    Cancer Invest; 2015 Jul; 33(6):251-8. PubMed ID: 25951106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
    Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
    Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
    Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
    Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
    J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
    Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.